Data:
{
"symbol": "REGN",
"price": 804.395,
"marketCap": 82816479985,
"beta": 0.236,
"lastDividend": 3.7,
"range": "572.75-859.34",
"change": 22.355,
"changePercentage": 2.85855,
"volume": 40523,
"averageVolume": 799035,
"companyName": "Regeneron Pharmaceuticals, Inc.",
"currency": "USD",
"cik": "0000872589",
"isin": "US75886F1075",
"cusip": "75886F107",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.regeneron.com",
"description": "Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, diabetic retinopathy, and macular edema resulting from retinal vein occlusion (both central and branch). Other significant offerings are Dupixent, an injectable solution for atopic dermatitis and asthma in both adults and pediatric patients; Libtayo, indicated for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent, an injection prescribed for adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; REGEN-COV for COVID-19; and Kevzara, a solution targeting rheumatoid arthritis in adult patients. Furthermore, Regeneron provides Inmazeb for infections caused by Zaire ebolavirus; ARCALYST, an injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and Muckle-Wells syndrome; and ZALTRAP, an intravenous infusion used in the treatment of metastatic colorectal cancer. In addition to its existing product lineup, the company is actively engaged in developing novel product candidates aimed at addressing unmet medical needs in areas such as ocular diseases, allergic and inflammatory conditions, cardiovascular and metabolic disorders, infectious diseases, rare diseases, cancer, pain management, and hematologic conditions. Regeneron maintains extensive collaboration and licensing agreements with a diverse range of partners, including Sanofi, Bayer, Teva Pharmaceutical Industries Ltd., Mitsubishi Tanabe Pharma Corporation, Alnylam Pharmaceuticals, Inc., Roche Pharmaceuticals, and Kiniksa Pharmaceuticals, Ltd. It also holds agreements with entities such as the U.S. Department of Health and Human Services, Zai Lab Limited, Intellia Therapeutics, Inc., the Biomedical Advanced Research Development Authority, and AstraZeneca PLC. The company was founded in 1988 and its corporate headquarters are situated in Tarrytown, New York.",
"ceo": "Leonard S. Schleifer",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "15410",
"phone": "914 847 7000",
"address": "777 Old Saw Mill River Road",
"city": "Tarrytown",
"state": "NY",
"zip": "10591-6707",
"image": "https://images.financialmodelingprep.com/symbol/REGN.png",
"ipoDate": "1991-04-02",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"price": 804.395,
"changePercentage": 2.85855,
"change": 22.355,
"volume": 40523,
"dayLow": 793.175,
"dayHigh": 805.75,
"yearHigh": 859.34,
"yearLow": 572.75,
"marketCap": 82816479985,
"priceAvg50": 790.8068,
"priceAvg200": 735.46625,
"exchange": "NASDAQ",
"open": 793.85,
"previousClose": 782.04,
"timestamp": 1792503733,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-09-09",
"v": 805.6715,
"c": 807.65
},
{
"t": "2026-09-10",
"v": 795.2994,
"c": 793.26
},
{
"t": "2026-09-11",
"v": 783.3497,
"c": 781.49
},
{
"t": "2026-09-14",
"v": 792.2096,
"c": 793.74
},
{
"t": "2026-09-15",
"v": 776.0258,
"c": 774.11
},
{
"t": "2026-09-16",
"v": 775.6868,
"c": 774.61
},
{
"t": "2026-09-17",
"v": 785.9671,
"c": 789.45
},
{
"t": "2026-09-18",
"v": 785.0749,
"c": 784.85
},
{
"t": "2026-09-21",
"v": 796.0033,
"c": 798.17
},
{
"t": "2026-09-22",
"v": 805.4001,
"c": 803.9
},
{
"t": "2026-09-23",
"v": 800.437,
"c": 801.82
},
{
"t": "2026-09-24",
"v": 796.6169,
"c": 796.02
},
{
"t": "2026-09-25",
"v": 788.5417,
"c": 788.04
},
{
"t": "2026-09-28",
"v": 756.3627,
"c": 752.25
},
{
"t": "2026-09-29",
"v": 749.0378,
"c": 750.51
},
{
"t": "2026-09-30",
"v": 755.9161,
"c": 758.27
},
{
"t": "2026-10-01",
"v": 738.5855,
"c": 734.81
},
{
"t": "2026-10-02",
"v": 735.0258,
"c": 735.2
},
{
"t": "2026-10-05",
"v": 727.4833,
"c": 726.47
},
{
"t": "2026-10-06",
"v": 735.8768,
"c": 738.72
},
{
"t": "2026-10-07",
"v": 743.9764,
"c": 742.12
},
{
"t": "2026-10-08",
"v": 734.2745,
"c": 739.57
},
{
"t": "2026-10-09",
"v": 746.1476,
"c": 746.54
},
{
"t": "2026-10-12",
"v": 763.3466,
"c": 762.81
},
{
"t": "2026-10-13",
"v": 753.289,
"c": 753.12
},
{
"t": "2026-10-14",
"v": 774.616,
"c": 778.36
},
{
"t": "2026-10-15",
"v": 800.3434,
"c": 796.34
},
{
"t": "2026-10-16",
"v": 792.8546,
"c": 790.74
},
{
"t": "2026-10-19",
"v": 785.3359,
"c": 782.04
},
{
"t": "2026-10-20",
"v": 797.4498,
"c": 804.63
}
],
"vwap_summary": {
"days": 30,
"days_above": 13,
"days_below": 17,
"pct_days_above": 43,
"position": "above",
"gap_pct": 0.9,
"streak_days": 1
}
}
Data:
{
"volume": 40523,
"avgVolume": 799035,
"short_ratio": [
{
"symbol": "REGN",
"file_date": "2026-10-19",
"date": "20261019",
"short_volume": 96995,
"short_exempt_volume": 292,
"total_volume": 170006,
"short_volume_ratio": 0.5705,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 735.24,
"vah": 779.67,
"val": 722.86,
"profile": [
{
"price": 723.59,
"volume": 45055
},
{
"price": 725.05,
"volume": 79959
},
{
"price": 726.5,
"volume": 220840
},
{
"price": 727.96,
"volume": 172706
},
{
"price": 729.42,
"volume": 118691
},
{
"price": 730.87,
"volume": 202797
},
{
"price": 732.33,
"volume": 201239
},
{
"price": 733.79,
"volume": 195271
},
{
"price": 735.24,
"volume": 457371
},
{
"price": 736.7,
"volume": 317156
},
{
"price": 738.16,
"volume": 206979
},
{
"price": 739.61,
"volume": 166587
},
{
"price": 741.07,
"volume": 153280
},
{
"price": 742.53,
"volume": 197731
},
{
"price": 743.98,
"volume": 163329
},
{
"price": 745.44,
"volume": 299124
},
{
"price": 746.9,
"volume": 340058
},
{
"price": 748.35,
"volume": 230405
},
{
"price": 749.81,
"volume": 333050
},
{
"price": 751.27,
"volume": 266995
},
{
"price": 752.72,
"volume": 260110
},
{
"price": 754.18,
"volume": 271673
},
{
"price": 755.64,
"volume": 180862
},
{
"price": 757.09,
"volume": 160128
},
{
"price": 758.55,
"volume": 361162
},
{
"price": 760.01,
"volume": 194639
},
{
"price": 761.46,
"volume": 192876
},
{
"price": 762.92,
"volume": 102263
},
{
"price": 764.38,
"volume": 199546
},
{
"price": 765.83,
"volume": 207369
},
{
"price": 767.29,
"volume": 117843
},
{
"price": 768.75,
"volume": 14350
},
{
"price": 770.2,
"volume": 38676
},
{
"price": 771.66,
"volume": 75531
},
{
"price": 773.12,
"volume": 36044
},
{
"price": 774.57,
"volume": 25088
},
{
"price": 776.03,
"volume": 51747
},
{
"price": 777.49,
"volume": 63563
},
{
"price": 778.94,
"volume": 162949
},
{
"price": 780.4,
"volume": 88504
},
{
"price": 781.86,
"volume": 78155
},
{
"price": 783.31,
"volume": 48149
},
{
"price": 784.77,
"volume": 47728
},
{
"price": 786.23,
"volume": 150136
},
{
"price": 787.68,
"volume": 205657
},
{
"price": 789.14,
"volume": 251931
},
{
"price": 790.6,
"volume": 213342
},
{
"price": 792.05,
"volume": 99013
},
{
"price": 793.51,
"volume": 149240
},
{
"price": 794.97,
"volume": 325112
},
{
"price": 796.42,
"volume": 187190
},
{
"price": 797.88,
"volume": 144699
},
{
"price": 799.34,
"volume": 142676
},
{
"price": 800.79,
"volume": 156806
},
{
"price": 802.25,
"volume": 248443
},
{
"price": 803.71,
"volume": 86256
},
{
"price": 805.16,
"volume": 149307
},
{
"price": 806.62,
"volume": 96242
},
{
"price": 808.08,
"volume": 19241
},
{
"price": 809.54,
"volume": 17563
}
],
"sessions": 20
}
}
Data:
{
"symbol": "REGN",
"marketCap": 82788033521,
"enterpriseValueTTM": 82245869319,
"evToSalesTTM": 5.299029496610814,
"evToOperatingCashFlowTTM": 18.52859312168002,
"evToFreeCashFlowTTM": 23.373415917828446,
"evToEBITDATTM": 14.31631887321739,
"netDebtToEBITDATTM": -0.0816,
"currentRatioTTM": 3.33526199689003,
"incomeQualityTTM": 1.0263589530343984,
"grahamNumberTTM": 537.4702536536427,
"grahamNetNetTTM": 42.95744680851064,
"taxBurdenTTM": 0.8379210220673635,
"interestBurdenTTM": 0.9893898188225381,
"workingCapitalTTM": 12915400000,
"investedCapitalTTM": 19684100000,
"returnOnAssetsTTM": 0.10373112868439971,
"operatingReturnOnAssetsTTM": 0.09612972585558144,
"returnOnTangibleAssetsTTM": 0.10709249335728176,
"returnOnEquityTTM": 0.13813240281357775,
"returnOnInvestedCapitalTTM": 0.09189738641274828,
"returnOnCapitalEmployedTTM": 0.10967308850422935,
"earningsYieldTTM": 0.05206151326120928,
"freeCashFlowYieldTTM": 0.042541172319386415,
"capexToOperatingCashFlowTTM": 0.20727919330152156,
"capexToDepreciationTTM": 1.7421490730230798,
"capexToRevenueTTM": 0.059280192086104015,
"salesGeneralAndAdministrativeToRevenueTTM": 0.17654669868101733,
"researchAndDevelopementToRevenueTTM": 0.4159204876824142,
"stockBasedCompensationToRevenueTTM": 0.06351587092122796,
"intangiblesToTotalAssetsTTM": 0.03138749101365924,
"averageReceivablesTTM": 6148200000,
"averagePayablesTTM": 1093200000,
"averageInventoryTTM": 3093950000,
"daysOfSalesOutstandingTTM": 154.25923899399407,
"daysOfPayablesOutstandingTTM": 179.90072700990603,
"daysOfInventoryOutstandingTTM": 478.6231452744356,
"operatingCycleTTM": 632.8823842684296,
"cashConversionCycleTTM": 452.98165725852357,
"freeCashFlowToEquityTTM": 3436600000,
"freeCashFlowToFirmTTM": 3483020824.622532,
"tangibleAssetValueTTM": 30401200000,
"netCurrentAssetValueTTM": 8427000000,
"grossProfitMarginTTM": 0.8485905746490116,
"ebitMarginTTM": 0.33611205881027634,
"ebitdaMarginTTM": 0.3701391079325639,
"operatingProfitMarginTTM": 0.25556335172227335,
"pretaxProfitMarginTTM": 0.33254584897036954,
"continuousOperationsProfitMarginTTM": 0.27864715765351117,
"netProfitMarginTTM": 0.27864715765351117,
"bottomLineProfitMarginTTM": 0.27864715765351117,
"receivablesTurnoverTTM": 2.3661467694276053,
"payablesTurnoverTTM": 2.0288967480376088,
"inventoryTurnoverTTM": 0.762604156534708,
"fixedAssetTurnoverTTM": 2.845756471083918,
"assetTurnoverTTM": 0.37226695422957107,
"quickRatioTTM": 2.7775829023975698,
"solvencyRatioTTM": 0.484808863159996,
"cashRatioTTM": 0.44403862148772283,
"priceToEarningsRatioTTM": 19.183619866284623,
"priceToEarningsGrowthRatioTTM": 61.60893303210651,
"forwardPriceToEarningsGrowthRatioTTM": 0.5535492150378883,
"priceToEarningsDilutedRatioTTM": 19.8716299777393,
"priceToEarningsDilutedGrowthRatioTTM": 10.51341703355599,
"priceToBookRatioTTM": 2.6196775251490014,
"priceToSalesRatioTTM": 5.3245359948373645,
"priceToFreeCashFlowRatioTTM": 23.48592217808569,
"priceToOperatingCashFlowRatioTTM": 18.698252003241198,
"debtToAssetsRatioTTM": 0.04760603882099209,
"debtToEquityRatioTTM": 0.06264703099870707,
"debtToCapitalRatioTTM": 0.058953753383030244,
"longTermDebtToCapitalRatioTTM": 0.058953753383030244,
"financialLeverageRatioTTM": 1.315947147677462,
"workingCapitalTurnoverRatioTTM": 1.1942006926267157,
"operatingCashFlowRatioTTM": 0.8033124796586265,
"operatingCashFlowSalesRatioTTM": 0.28599200499526867,
"freeCashFlowOperatingCashFlowRatioTTM": 0.7927208066984784,
"debtServiceCoverageRatioTTM": 88.67689530685921,
"interestCoverageRatioTTM": 71.66245487364621,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 2.236383771267492,
"capitalExpenditureCoverageRatioTTM": 4.8244109023781085,
"dividendPaidAndCapexCoverageRatioTTM": 3.4191165153147605,
"dividendPayoutRatioTTM": 0.08743964700718461,
"dividendYieldTTM": 0.00460537,
"revenuePerShareTTM": 150.23887814313346,
"netIncomePerShareTTM": 41.86363636363637,
"interestDebtPerShareTTM": 19.748549323017407,
"cashPerShareTTM": 77.31721470019342,
"bookValuePerShareTTM": 306.6827852998066,
"tangibleBookValuePerShareTTM": 294.0154738878143,
"shareholdersEquityPerShareTTM": 306.6827852998066,
"operatingCashFlowPerShareTTM": 42.967117988394584,
"capexPerShareTTM": 8.906189555125726,
"freeCashFlowPerShareTTM": 34.060928433268856,
"netIncomePerEBTTTM": 0.8379210220673635,
"ebtPerEbitTTM": 1.3012266693534167,
"priceToFairValueTTM": 2.6196775251490014,
"debtToMarketCapTTM": 0.02401738904840245,
"effectiveTaxRateTTM": 0.16207897793263648,
"enterpriseValueMultipleTTM": 14.303629446782608,
"dividendPerShareTTM": 3.7,
"revenue_history": [
{
"date": "2025",
"revenue": 14342900000
}
],
"dcf": {
"symbol": "REGN",
"date": "2026-10-20",
"dcf": 1828.276456808211,
"Stock Price": 782.04
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "REGN",
"reportedCurrency": "USD",
"cik": "0000872589",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:08:38",
"fiscalYear": "2025",
"period": "FY",
"revenue": 14342900000,
"costOfRevenue": 2100700000,
"grossProfit": 12242200000,
"researchAndDevelopmentExpenses": 5850200000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 2700000000,
"otherExpenses": 114100000,
"operatingExpenses": 8664300000,
"costAndExpenses": 10765000000,
"netInterestIncome": 673000000,
"interestIncome": 716800000,
"interestExpense": 43800000,
"depreciationAndAmortization": 543700000,
"ebitda": 5818200000,
"ebit": 5274500000,
"nonOperatingIncomeExcludingInterest": -1696600000,
"operatingIncome": 3577900000,
"totalOtherIncomeExpensesNet": 1652800000,
"incomeBeforeTax": 5230700000,
"incomeTaxExpense": 725800000,
"netIncomeFromContinuingOperations": 4504900000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 4504900000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 4504900000,
"eps": 43.07,
"epsDiluted": 41.48,
"weightedAverageShsOut": 104600000,
"weightedAverageShsOutDil": 108600000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "REGN",
"reportedCurrency": "USD",
"cik": "0000872589",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:08:38",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 3118100000,
"shortTermInvestments": 5487100000,
"cashAndShortTermInvestments": 8605200000,
"netReceivables": 5741100000,
"accountsReceivables": 5741100000,
"otherReceivables": 0,
"inventory": 3200800000,
"prepaids": 0,
"otherCurrentAssets": 474800000,
"totalCurrentAssets": 18021900000,
"propertyPlantEquipmentNet": 5120400000,
"goodwill": 0,
"intangibleAssets": 1257400000,
"goodwillAndIntangibleAssets": 1257400000,
"longTermInvestments": 10260600000,
"taxAssets": 4077200000,
"otherNonCurrentAssets": 1821200000,
"totalNonCurrentAssets": 22536800000,
"otherAssets": 0,
"totalAssets": 40558700000,
"totalPayables": 1290300000,
"accountPayables": 939000000,
"otherPayables": 351300000,
"accruedExpenses": 2525100000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 553000000,
"otherCurrentLiabilities": 0,
"totalCurrentLiabilities": 4368400000,
"longTermDebt": 1985900000,
"capitalLeaseObligationsNonCurrent": 720000000,
"deferredRevenueNonCurrent": 208700000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 2018800000,
"totalNonCurrentLiabilities": 4933400000,
"otherLiabilities": 0,
"capitalLeaseObligations": 720000000,
"totalLiabilities": 9301800000,
"treasuryStock": -18612800000,
"preferredStock": 0,
"commonStock": 100000,
"retainedEarnings": 35797100000,
"additionalPaidInCapital": 13995000000,
"accumulatedOtherComprehensiveIncomeLoss": 77500000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 31256900000,
"totalEquity": 31256900000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 40558700000,
"totalInvestments": 15747700000,
"totalDebt": 2705900000,
"netDebt": -412200000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "REGN",
"reportedCurrency": "USD",
"cik": "0000872589",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:08:38",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 4504900000,
"depreciationAndAmortization": 543700000,
"deferredIncomeTax": -785400000,
"stockBasedCompensation": 993700000,
"changeInWorkingCapital": 532600000,
"accountsReceivables": 498100000,
"inventory": -275300000,
"accountsPayables": 736800000,
"otherWorkingCapital": -427000000,
"otherNonCashItems": -810600000,
"netCashProvidedByOperatingActivities": 4978900000,
"investmentsInPropertyPlantAndEquipment": -1213700000,
"acquisitionsNet": -3300000,
"purchasesOfInvestments": -10958300000,
"salesMaturitiesOfInvestments": 11546200000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -629100000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -3334800000,
"netCommonStockIssuance": -3334800000,
"commonStockIssuance": 635900000,
"commonStockRepurchased": -3970700000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": -370300000,
"commonDividendsPaid": -370300000,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -10300000,
"netCashProvidedByFinancingActivities": -3715400000,
"effectOfForexChangesOnCash": 300000,
"netChangeInCash": 634700000,
"cashAtEndOfPeriod": 3123700000,
"cashAtBeginningOfPeriod": 2489000000,
"operatingCashFlow": 4978900000,
"capitalExpenditure": -898400000,
"freeCashFlow": 4080500000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 803.41,
"rsi": 59.92162238959094,
"sma20": 763.858,
"sma50": 790.7140000000006,
"sma200": 735.6017499999999,
"adx": 18.68997593060763,
"atr": 22.77,
"atr_pct": 2.83,
"atr_expansion_pct": 7.7,
"di_plus": 28.6,
"di_minus": 15.0,
"high_52w": 852.03,
"low_52w": 557.73,
"structure": {
"ema8": 780.0991780723313,
"ema21": 772.8202251718608,
"ema50": 768.0020785737432,
"ema200": 730.3337893759737,
"ema10": 776.9011788361363,
"ema20": 772.7846621498263,
"ema10_slope_pct": 3.38,
"ema20_slope_pct": 1.55,
"trend_dir": "chop",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 4.0,
"_no_bars": false,
"macd": {
"macd": 1.853,
"signal": -4.928,
"histogram": 6.781
},
"bollinger": {
"mid": 763.86,
"upper": 813.78,
"lower": 713.94,
"width_pct": 13.07
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": true,
"candles_since": 2,
"intraday_support": false
},
"momentum": {
"roc10": 8.8,
"ret_3d": 0.89,
"ret_5d": 6.68,
"roc10_accel": 8.41,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.06,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 4.95,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 642739758.8249999
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": true,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 47.0
}
}
}
}
Data:
{
"prior_day": {
"high": 805.75,
"low": 789.69,
"close": 804.63,
"date": "2026-10-20"
},
"woodie_pivots": {
"PP": 801.17,
"R1": 812.66,
"S1": 796.6,
"R2": 817.23,
"S2": 785.12
},
"swing": {
"high_20d": 813.53,
"low_20d": 722.02,
"high_60d": 859.34,
"low_60d": 676.46
},
"orb": {
"high": 805.75,
"low": 789.69,
"date": "2026-10-20"
},
"vwap": 800.75,
"volume_profile": {
"poc": 735.24,
"vah": 779.67,
"val": 722.86,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 803.91,
"h1_ema9": 790.99,
"h1_ema21": 788.51,
"m15_trend": "up",
"m15_last": 803.91,
"m15_ema9": 789.45,
"m15_ema21": 787.99,
"rvol_intraday": 0.89,
"as_of_et": "2026-10-20 09:40"
},
"premarket": {
"date": "2026-10-20",
"high": 793.35,
"low": 769.98,
"last": 793.35,
"volume": 579,
"gap_pct": 1.45,
"path": "07:15 787.00 -> 07:50 788.00 -> 08:05 769.98 -> 08:55 788.00 -> 09:25 793.35",
"bars": 5,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-09-16",
"o": 775.82,
"h": 779.98,
"l": 771.8001,
"c": 774.61,
"v": 382945.259228
},
{
"d": "2026-09-17",
"o": 781.18,
"h": 789.99,
"l": 774.775,
"c": 789.45,
"v": 702816.064167
},
{
"d": "2026-09-18",
"o": 787.34,
"h": 794.73,
"l": 779.65,
"c": 784.85,
"v": 2473436.972067
},
{
"d": "2026-09-21",
"o": 786.03,
"h": 801.44,
"l": 779.96,
"c": 798.17,
"v": 704526.634685
},
{
"d": "2026-09-22",
"o": 802.48,
"h": 811.6599,
"l": 791.31,
"c": 803.9,
"v": 600266.320718
},
{
"d": "2026-09-23",
"o": 805.23,
"h": 813.53,
"l": 790.02,
"c": 801.82,
"v": 721110.370868
},
{
"d": "2026-09-24",
"o": 801.59,
"h": 807.205,
"l": 789.39,
"c": 796.02,
"v": 602653.753131
},
{
"d": "2026-09-25",
"o": 803.87,
"h": 803.87,
"l": 784.13,
"c": 788.04,
"v": 592145.932373
},
{
"d": "2026-09-28",
"o": 778.09,
"h": 780.945,
"l": 750,
"c": 752.25,
"v": 1149832.487243
},
{
"d": "2026-09-29",
"o": 745.85,
"h": 752.47,
"l": 741.829,
"c": 750.51,
"v": 804336.272925
},
{
"d": "2026-09-30",
"o": 749.84,
"h": 763.72,
"l": 742.94,
"c": 758.27,
"v": 872457.427192
},
{
"d": "2026-10-01",
"o": 766.53,
"h": 777.43,
"l": 726.02,
"c": 734.81,
"v": 1042865.876238
},
{
"d": "2026-10-02",
"o": 740.5,
"h": 742.5,
"l": 729.1983,
"c": 735.2,
"v": 613949.528353
},
{
"d": "2026-10-05",
"o": 734.365,
"h": 736.42,
"l": 722.02,
"c": 726.47,
"v": 695028.421928
},
{
"d": "2026-10-06",
"o": 734.61,
"h": 740.51,
"l": 727.155,
"c": 738.72,
"v": 615062.264263
},
{
"d": "2026-10-07",
"o": 738.05,
"h": 753.68,
"l": 734.18,
"c": 742.12,
"v": 626433.409289
},
{
"d": "2026-10-08",
"o": 742.12,
"h": 744.5,
"l": 723.647,
"c": 739.57,
"v": 500295.888196
},
{
"d": "2026-10-09",
"o": 737.2,
"h": 751.27,
"l": 732.83,
"c": 746.54,
"v": 466026.193013
},
{
"d": "2026-10-12",
"o": 748.67,
"h": 768.6581,
"l": 744.96,
"c": 762.81,
"v": 618293.902726
},
{
"d": "2026-10-13",
"o": 762.485,
"h": 765.6,
"l": 743.5666,
"c": 753.12,
"v": 629557.125291
},
{
"d": "2026-10-14",
"o": 758.16,
"h": 781.84,
"l": 755.21,
"c": 778.36,
"v": 879091.203124
},
{
"d": "2026-10-15",
"o": 802.33,
"h": 809.49,
"l": 792.58,
"c": 796.34,
"v": 798909.17508
},
{
"d": "2026-10-16",
"o": 803.01,
"h": 805.675,
"l": 787.32,
"c": 790.74,
"v": 653725.373628
},
{
"d": "2026-10-19",
"o": 792.59,
"h": 800,
"l": 780.83,
"c": 782.04,
"v": 489580.261376
},
{
"d": "2026-10-20",
"o": 793.85,
"h": 805.75,
"l": 789.69,
"c": 804.63,
"v": 38878.982326
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 2.02,
"etf_rvol": 0.43,
"rs_5d": 4.25,
"leading": true
}
Data:
{
"estimates": [
{
"symbol": "REGN",
"date": "2030-12-31",
"revenueLow": 19816410458,
"revenueHigh": 24339799047,
"revenueAvg": 22491873833,
"ebitdaLow": 9195649136,
"ebitdaHigh": 11736104307,
"ebitdaAvg": 10698260817,
"ebitLow": 8271672184,
"ebitHigh": 10812127355,
"ebitAvg": 9774283865,
"netIncomeLow": 7367760727,
"netIncomeHigh": 9646394002,
"netIncomeAvg": 8715511718,
"sgaExpenseLow": 3476758332,
"sgaExpenseHigh": 4270379810,
"sgaExpenseAvg": 3946164211,
"epsAvg": 80.25333,
"epsHigh": 88.82499,
"epsLow": 67.8431,
"numAnalystsRevenue": 10,
"numAnalystsEps": 4
},
{
"symbol": "REGN",
"date": "2029-12-31",
"revenueLow": 18827300291,
"revenueHigh": 23124909865,
"revenueAvg": 21369221417,
"ebitdaLow": 8651194204,
"ebitdaHigh": 11045490709,
"ebitdaAvg": 10067357066,
"ebitLow": 7799079905,
"ebitHigh": 10193376410,
"ebitAvg": 9215242767,
"netIncomeLow": 6943874289,
"netIncomeHigh": 9091412159,
"netIncomeAvg": 8214085965,
"sgaExpenseLow": 3303220494,
"sgaExpenseHigh": 4057229396,
"sgaExpenseAvg": 3749196594,
"epsAvg": 75.63615,
"epsHigh": 83.71466,
"epsLow": 63.93991,
"numAnalystsRevenue": 10,
"numAnalystsEps": 2
},
{
"symbol": "REGN",
"date": "2028-12-31",
"revenueLow": 17649309264,
"revenueHigh": 22618801055,
"revenueAvg": 20094626287,
"ebitdaLow": 8272568364,
"ebitdaHigh": 10318046268,
"ebitdaAvg": 9128672898,
"ebitLow": 7495165677,
"ebitHigh": 9540643581,
"ebitAvg": 8351270211,
"netIncomeLow": 6671281771,
"netIncomeHigh": 8505950640,
"netIncomeAvg": 7439155300,
"sgaExpenseLow": 3096543804,
"sgaExpenseHigh": 3968433395,
"sgaExpenseAvg": 3525570865,
"epsAvg": 69.6579,
"epsHigh": 78.32367,
"epsLow": 61.42985,
"numAnalystsRevenue": 21,
"numAnalystsEps": 7
},
{
"symbol": "REGN",
"date": "2027-12-31",
"revenueLow": 16964108728,
"revenueHigh": 20156501905,
"revenueAvg": 18741104283,
"ebitdaLow": 6998337817,
"ebitdaHigh": 8917446120,
"ebitdaAvg": 8203543405,
"ebitLow": 6297162005,
"ebitHigh": 8216270308,
"ebitAvg": 7502367593,
"netIncomeLow": 5596745577,
"netIncomeHigh": 7318068625,
"netIncomeAvg": 6677741450,
"sgaExpenseLow": 2976326438,
"sgaExpenseHigh": 3536426846,
"sgaExpenseAvg": 3288097539,
"epsAvg": 62.5594,
"epsHigh": 67.38553,
"epsLow": 51.53541,
"numAnalystsRevenue": 17,
"numAnalystsEps": 9
}
],
"price_target": {
"symbol": "REGN",
"targetHigh": 1030,
"targetLow": 750,
"targetConsensus": 856.8,
"targetMedian": 855
},
"ratings": {
"symbol": "REGN",
"rating": "A",
"overallScore": 4,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 4,
"returnOnAssetsScore": 5,
"debtToEquityScore": 3,
"priceToEarningsScore": 3,
"priceToBookScore": 3
},
"grades": [
{
"symbol": "REGN",
"date": "2026-10-19",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-10-15",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "REGN",
"date": "2026-10-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-10-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-10-07",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-10-06",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-10-01",
"gradingCompany": "Argus Research",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "REGN",
"date": "2026-10-01",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-09-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-09-10",
"gradingCompany": "HSBC",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-08-17",
"gradingCompany": "Leerink Partners",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-08-03",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-08-03",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-31",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-31",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-31",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-31",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-31",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-21",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-09",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-07",
"gradingCompany": "Benchmark",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "REGN",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-06",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-07-06",
"gradingCompany": "HSBC",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-19",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-18",
"gradingCompany": "BMO Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-05-01",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-30",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-30",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-30",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-30",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-23",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-23",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-04-08",
"gradingCompany": "Bernstein",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-03-31",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-03-02",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-09",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-02-02",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-01-22",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-01-08",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2026-01-07",
"gradingCompany": "B of A Securities",
"previousGrade": "Underperform",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "REGN",
"date": "2025-12-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-12-10",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-12-04",
"gradingCompany": "BMO Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-12-04",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-12-03",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Equal Weight",
"action": "downgrade"
},
{
"symbol": "REGN",
"date": "2025-11-24",
"gradingCompany": "Scotiabank",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-11-20",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-11-07",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "B of A Securities",
"previousGrade": "Underperform",
"newGrade": "Underperform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-29",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "REGN",
"date": "2025-10-23",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $865",
"url": "https://www.benzinga.com/news/26/10/62445126/piper-sandler-maintains-overweight-regeneron-pharmaceuticals-raises-price-target-865",
"source": "benzinga",
"date": "2026-10-19T16:23:34.503000+00:00",
"summary": "Piper Sandler analyst Biren Amin maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price target from $854 to $865.",
"image": ""
},
{
"title": "Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market",
"url": "https://www.fool.com/investing/2026/10/19/forget-eli-lilly-and-novo-this-biotech-could-be-a-surprising-winner-in-the-weight-loss-market/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-19T14:24:01Z",
"summary": "Regeneron Pharmaceuticals is emerging as a competitive player in the rapidly growing weight loss market with two differentiated candidates: olatorepatide, which shows better gastrointestinal tolerability than competitors with 19% mean weight loss, and trevogrumab, designed to pre",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F8141a00920997097558d32a6115507aa98a25315-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?",
"url": "https://finance.yahoo.com/healthcare/articles/zenkudas-multi-indication-potential-drive-121000409.html",
"source": "Yahoo! Finance",
"date": "2026-10-19T12:10:00Z",
"summary": "Kodiak Sciences KOD could unlock significant growth opportunities through Zenkuda (tarcocimab tedromer), its late-stage investigational therapy for retinal diseases. Positive phase III results across wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and re",
"image": "https://s.yimg.com/lo/mysterio/api/1994f26a823de6d4f4e6a0cbed600ab64b791e3ac76bf97e87d87fce73a3b3c9/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fzacks.com%2F41b7bdd28f63138df08f17b665d3589a.jpg"
},
{
"title": "Frank Rimerman Advisors LLC Acquires 876 Shares of Regeneron Pharmaceuticals, Inc. $REGN",
"url": "https://www.defenseworld.net/2026/10/19/frank-rimerman-advisors-llc-acquires-876-shares-of-regeneron-pharmaceuticals-inc-regn.html",
"source": "Defense World",
"date": "2026-10-19 04:48:51",
"summary": "Frank Rimerman Advisors LLC lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 153.7% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 1,446 shares of the biopharmaceutical company's stock after purchasing an add",
"image": "https://images.financialmodelingprep.com/news/frank-rimerman-advisors-llc-acquires-876-shares-of-regeneron-20261019.png"
},
{
"title": "Insider Selling: Regeneron Pharmaceuticals (NASDAQ:REGN) Insider Sells $3,204,386.90 in Stock",
"url": "https://www.defenseworld.net/2026/10/18/insider-selling-regeneron-pharmaceuticals-nasdaqregn-insider-sells-3204386-90-in-stock.html",
"source": "Defense World",
"date": "2026-10-18 04:09:20",
"summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN - Get Free Report) insider Andrew Murphy sold 4,147 shares of the stock in a transaction that occurred on Wednesday, October 14th. The stock was sold at an average price of $772.70, for a total value of $3,204,386.90. Following the tr",
"image": "https://images.financialmodelingprep.com/news/insider-selling-regeneron-pharmaceuticals-nasdaqregn-insider-sells-320438690-in-20261018.png"
},
{
"title": "Regeneron\u2019s Murphy sells $3.2 million in stock under plan (NASDAQ: REGN)",
"url": "https://www.defenseworld.net/2026/10/18/regenerons-murphy-sells-3-2-million-in-stock-under-plan-nasdaq-regn.html",
"source": "Defense World",
"date": "2026-10-18 02:03:03",
"summary": "What happened Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) said Co-Chief Scientific Officer Andrew J. Murphy sold 4,147 shares on 10/14/2026. The shares sold for $753.76 to $781.47 each and brought in about $3.20 million, according to the Form 4. The filing says the trades were",
"image": "https://images.financialmodelingprep.com/news/regenerons-murphy-sells-32-million-in-stock-under-plan-20261018.png"
},
{
"title": "Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share",
"url": "https://www.fool.com/investing/2026/10/17/forget-eylea-regenerons-real-value-may-be-hiding-i/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-17T19:24:00Z",
"summary": "Despite declining Eylea sales, Regeneron's strong performance is driven by Dupixent, a blockbuster drug developed with Sanofi that generated $6 billion in global sales with 38% year-over-year growth. The company's Q2 revenue grew 17% to $4.3 billion, with Dupixent collaboration r",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F890467%2Fregeneron-logo-source-tmf.png&w=1200&op=resize"
},
{
"title": "Libtayo\u00ae (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types",
"url": "https://www.globenewswire.com/news-release/2026/10/16/3382494/0/en/libtayo-cemiplimab-recommended-for-eu-approval-by-the-chmp-for-updated-dosing-regimen-across-all-approved-cancer-types.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-16T11:00:00Z",
"summary": "The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of an alternative dosing schedule for Libtayo (cemiplimab) across all approved cancer indications. The new regimen allows for extended dosing",
"image": "https://ml.globenewswire.com/Resource/Download/add5ebc7-88c9-49dc-8834-abbb07c622d1"
},
{
"title": "2,281 Shares in Regeneron Pharmaceuticals, Inc. $REGN Bought by First Citizens Bank & Trust Co.",
"url": "https://www.defenseworld.net/2026/10/16/2281-shares-in-regeneron-pharmaceuticals-inc-regn-bought-by-first-citizens-bank-trust-co.html",
"source": "Defense World",
"date": "2026-10-16 04:44:24",
"summary": "First Citizens Bank and Trust Co. bought a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,281 shares of the bioph",
"image": "https://images.financialmodelingprep.com/news/2281-shares-in-regeneron-pharmaceuticals-inc-regn-bought-by-20261016.png"
},
{
"title": "Can Nektar's Pipeline Progress Create Long-Term Value Amid Rivalry?",
"url": "https://www.zacks.com/stock/news/3008784/can-nektar-s-pipeline-progress-create-long-term-value-amid-rivalry?cid=CS-ZC-FT-analyst_blog|quick_take-3008784",
"source": "Zacks Investment Research",
"date": "2026-10-15T15:31:00Z",
"summary": "Nektar Therapeutics (NKTR) initiated two Phase III studies (ZENITH AD-1 and ZENITH AD-2) for rezpeg in atopic dermatitis in July 2026, with top-line data expected mid-2028. The company plans Phase III studies for alopecia areata in early 2027 and expects Type I diabetes data in 2",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "Here's Why You Should Add EYPT Stock to Your Portfolio Now",
"url": "https://www.zacks.com/stock/news/3008694/here-s-why-you-should-add-eypt-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-3008694",
"source": "Zacks Investment Research",
"date": "2026-10-15T14:04:00Z",
"summary": "EyePoint (EYPT) reported mixed results from its LUGANO wet AMD study, with Duravyu failing to meet the primary endpoint but showing encouraging secondary endpoint results. The company expects LUCIA study data in Q4 2026 and has completed enrollment in two phase III DME studies wi",
"image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg"
},
{
"title": "Here are Thursday's biggest analyst calls: Nvidia, CoreWeave, Walmart, Crocs, CarMax, Regeneron & more",
"url": "https://www.cnbc.com/2026/10/15/thursday-big-wall-street-analyst-calls-like-coreweave.html",
"source": "CNBC",
"date": "2026-10-15T12:17:33Z",
"summary": "Here are Thursday's biggest calls on Wall Street: Deutsche Bank upgrades Walmart to buy from hold Deutsche said it sees \"more ways to win.\" \"We are upgrading WMT to Buy as we see a more favorable setup into 2027.\" Read more. Baird upgrades Bank of America to outperform from neutr",
"image": "https://image.cnbcfm.com/api/v1/image/104098790-RTXSHQY.jpg?v=1741621121&w=1920&h=1080"
},
{
"title": "Here Are Thursday\u2019s Top Wall Street Analyst Research Calls: AngloGold Ashanti, Bank of America, Cirrus Logic, Crocs, Diamondback Energy, Devon Energy, Netflix, PayPal, Spotify Technolgy , and More",
"url": "https://247wallst.com/investing/2026/10/15/here-are-thursdays-top-wall-street-analyst-research-calls-anglogold-ashanti-bank-of-america-cirrus-logic-crocs-diamondback-energy-devon-energy-netflix-paypal-spotify-technolgy-and/",
"source": "247 Wallst",
"date": "2026-10-15 08:10:11",
"summary": "Hotter-than-expected inflation sent stocks and crypto tumbling Wednesday, and Wall Street analysts wasted no time reshuffling their targets on Thursday, with major calls hitting Bank of America, Netflix, PayPal, and several energy giants all at once.",
"image": "https://images.financialmodelingprep.com/news/here-are-thursdays-top-wall-street-analyst-research-calls-20261015.jpg"
},
{
"title": "Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?",
"url": "https://www.zacks.com/stock/news/3007283/which-pharma-stock-looks-more-attractive-sanofi-or-abbvie?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-3007283",
"source": "Zacks Investment Research",
"date": "2026-10-14T15:09:00Z",
"summary": "Sanofi and AbbVie are compared as major pharmaceutical companies with different growth drivers. Sanofi, powered by Dupixent's strong performance and newer medicines, trades at a lower valuation (7.82x forward earnings) with a 4.5% dividend yield, while AbbVie relies on Skyrizi an",
"image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg"
},
{
"title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
"url": "https://www.zacks.com/stock/news/3006735/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-fundamental_analysis|zacks_education_earnings_esp-3006735",
"source": "Zacks Investment Research",
"date": "2026-10-14T11:55:04Z",
"summary": "The article highlights two medical stocks with positive Earnings Surprise Prediction (ESP) metrics that could potentially beat their quarterly earnings estimates. Regeneron (REGN) holds a #3 (Hold) rating with a +0.23% ESP ahead of its October 30, 2026 earnings release, while Dan",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default274.jpg"
},
{
"title": "Longleaf Partners Global Fund Q3 2026 Portfolio Review",
"url": "https://seekingalpha.com/article/4954231-longleaf-partners-global-fund-q3-2026-portfolio-review",
"source": "Seeking Alpha",
"date": "2026-10-14 16:27:00",
"summary": "Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition o",
"image": "https://images.financialmodelingprep.com/news/longleaf-partners-global-fund-q3-2026-portfolio-review-20261014.jpg"
},
{
"title": "Longleaf Partners Fund Q3 2026 Portfolio Review",
"url": "https://seekingalpha.com/article/4954038-longleaf-partners-fund-q3-2026-portfolio-review",
"source": "Seeking Alpha",
"date": "2026-10-14 07:02:00",
"summary": "The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building produ",
"image": "https://images.financialmodelingprep.com/news/longleaf-partners-fund-q3-2026-portfolio-review-20261014.jpg"
},
{
"title": "Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by NorthCrest Asset Manangement LLC",
"url": "https://www.defenseworld.net/2026/10/13/regeneron-pharmaceuticals-inc-regn-shares-bought-by-northcrest-asset-manangement-llc.html",
"source": "Defense World",
"date": "2026-10-13 07:25:04",
"summary": "NorthCrest Asset Manangement LLC boosted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 7.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,712 s",
"image": "https://images.financialmodelingprep.com/news/regeneron-pharmaceuticals-inc-regn-shares-bought-by-northcrest-asset-20261013.png"
},
{
"title": "Regeneron reports sustained efficacy for FOP treatment Pasatru By Investing.com",
"url": "https://www.investing.com/news/company-news/regeneron-reports-sustained-efficacy-for-fop-treatment-pasatru-93CH-4944943",
"source": "Investing.com",
"date": "2026-10-12T16:12:48Z",
"summary": "TARRYTOWN, N.Y. - Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced results from an 84-week extension of its Phase 3 OPTIMA trial evaluating Pasatru in adults with fibrodysplasia ossificans progressiva, according to a press release statement.\n\nThe data, presented today at th",
"image": "https://content-media.investing.com/news/LYNXMPEM4L1MC_1200_L.jpg"
},
{
"title": "Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?",
"url": "https://www.zacks.com/stock/news/3005301/will-regeneron-regn-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-fundamental_analysis|yseop_template_7-3005301",
"source": "Zacks Investment Research",
"date": "2026-10-12T15:10:03Z",
"summary": "Regeneron (REGN) is positioned to potentially beat earnings estimates in its upcoming October 30, 2026 report. The company has a strong track record of beating estimates with an average surprise of 27.03% over the past two quarters, most recently delivering a 42.90% surprise. Wit",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default305.jpg"
},
{
"title": "Regeneron Says Newly Approved Drug Shows Sustained Efficacy In Halting Rogue Bone Growth",
"url": "https://www.benzinga.com/news/health-care/26/10/62307403/regeneron-says-newly-approved-drug-shows-sustained-efficacy-in-halting-rogue-bone-growth",
"source": "Benzinga",
"date": "2026-10-12 13:34:58",
"summary": "Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on Monday shared encouraging 84-week findings from the Phase 3 OPTIMA trial for its drug Pasatru (garetosmab-grts).",
"image": "https://images.financialmodelingprep.com/news/regeneron-says-newly-approved-drug-shows-sustained-efficacy-in-20261012.jpg"
},
{
"title": "Why Regeneron (REGN) is a Top Value Stock for the Long-Term",
"url": "https://www.zacks.com/stock/news/3003752/why-regeneron-regn-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-fundamental_analysis|zacks_education_value_score-3003752",
"source": "Zacks Investment Research",
"date": "2026-10-09T12:40:02Z",
"summary": "Regeneron (REGN), a biotechnology company focused on severe medical conditions, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 13.47, and two analysts revised earni",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg"
},
{
"title": "Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD",
"url": "https://www.zacks.com/stock/news/3003080/bayer-seeks-kerendia-label-expansion-in-non-diabetic-ckd?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-3003080",
"source": "Zacks Investment Research",
"date": "2026-10-08T15:21:00Z",
"summary": "Bayer announced FDA acceptance of a supplemental new drug application for Kerendia (finerenone) to treat chronic kidney disease in non-diabetic patients. The approval is based on positive phase III FIND-CKD trial data showing the drug significantly delayed kidney disease progress",
"image": "https://staticx-tuner.zacks.com/images/articles/main/e9/1435.jpg"
},
{
"title": "Raymond James reiterates Regeneron stock rating on Eylea trends By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/raymond-james-reiterates-regeneron-stock-rating-on-eylea-trends-93CH-4938322",
"source": "Investing.com",
"date": "2026-10-08T10:06:51Z",
"summary": "Investing.com - Raymond James reiterated an Outperform rating and a $911.00 price target on Regeneron Pharmaceuticals (NASDAQ:REGN) stock. With shares currently trading at $742, the stock appears undervalued according to InvestingPro analysis, which shows a Fair Value significant",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4510G_1200_L.jpg"
},
{
"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT",
"url": "https://www.globenewswire.com/news-release/2026/10/06/3376115/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-eyepoint-inc-eypt.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-06T21:36:00Z",
"summary": "Pomerantz LLP is investigating securities fraud claims against EyePoint, Inc. following the company's announcement that its Phase 3 clinical trial for DURAVYU failed to meet its primary endpoint against Regeneron's Eylea. The stock plummeted 66.98% to $4.87 per share on August 17",
"image": "https://www.globenewswire.com/news-release/2026/10/06/3376115/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-eyepoint-inc-eypt.html"
}
]
Data:
[
{
"symbol": "REGN",
"date": "2026-10-30",
"epsActual": null,
"epsEstimated": 16.1,
"revenueActual": null,
"revenueEstimated": 4549237000,
"lastUpdated": "2026-10-20"
},
{
"symbol": "REGN",
"date": "2026-07-30",
"epsActual": 14.29,
"epsEstimated": 10.16,
"revenueActual": 4290700000,
"revenueEstimated": 3817252000,
"lastUpdated": "2026-10-20"
},
{
"symbol": "REGN",
"date": "2026-04-29",
"epsActual": 9.47,
"epsEstimated": 8.91,
"revenueActual": 3605400000,
"revenueEstimated": 3480534000,
"lastUpdated": "2026-07-29"
},
{
"symbol": "REGN",
"date": "2026-01-30",
"epsActual": 11.44,
"epsEstimated": 10.74,
"revenueActual": 3884300000,
"revenueEstimated": 3810747000,
"lastUpdated": "2026-04-30"
},
{
"symbol": "REGN",
"date": "2025-10-28",
"epsActual": 11.83,
"epsEstimated": 9.65,
"revenueActual": 3754300000,
"revenueEstimated": 3592157312,
"lastUpdated": "2026-01-26"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "REGN",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "REGN",
"periods": [
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 1276,
"price": 738.34
},
{
"file_period": "202608a",
"settlement_date": "20260814",
"quantity_fails": 60,
"price": 805.97
},
{
"file_period": "202608b",
"settlement_date": "20260820",
"quantity_fails": 21,
"price": 840.84
},
{
"file_period": "202609a",
"settlement_date": "20260909",
"quantity_fails": 341,
"price": 810.31
},
{
"file_period": "202609b",
"settlement_date": "20260917",
"quantity_fails": 8,
"price": 774.61
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-13",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "M-Exempt",
"securitiesOwned": 64833,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 17000,
"price": 381.92,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-13",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "F-InKind",
"securitiesOwned": 51980,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 12853,
"price": 754.58,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51974,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 6,
"price": 753.76,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51939,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 35,
"price": 755.91,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51923,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16,
"price": 757.68,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51899,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24,
"price": 758.16,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51885,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14,
"price": 759.96,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
},
{
"symbol": "REGN",
"filingDate": "2026-10-15",
"transactionDate": "2026-10-14",
"reportingCik": "0001796226",
"companyCik": "0000872589",
"transactionType": "S-Sale",
"securitiesOwned": 51811,
"reportingName": "MURPHY ANDREW J",
"typeOfOwner": "officer: Co-Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 74,
"price": 760.65,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/872589/000179622626000002/0001796226-26-000002-index.htm"
}
],
"congress": [
{
"symbol": "REGN",
"senateID": "A000383",
"disclosureDate": "2026-07-21",
"transactionDate": "2026-03-27",
"firstName": "Alan",
"lastName": "Armstrong",
"office": "Armstrong, Alan (Senator)",
"district": "",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/fda235b3-bad7-4637-8fa1-053f354d929c/"
},
{
"symbol": "REGN",
"senateID": "T000278",
"disclosureDate": "2024-05-15",
"transactionDate": "2024-04-04",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/dda61a64-82ed-4cc8-87e7-ef1d256c6565/"
},
{
"symbol": "REGN",
"senateID": "T000278",
"disclosureDate": "2023-05-12",
"transactionDate": "2023-04-03",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/0f75ebb1-f361-48c9-b347-b76366b49029/"
},
{
"symbol": "REGN",
"senateID": "T000278",
"disclosureDate": "2023-05-11",
"transactionDate": "2023-04-03",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/d4a78d56-71f0-4658-a22e-72a8b9de1816/"
},
{
"symbol": "REGN",
"senateID": "T000278",
"disclosureDate": "2022-04-08",
"transactionDate": "2022-03-30",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/0f1deb54-a350-4646-9365-899394573269/"
},
{
"symbol": "REGN",
"senateID": "T000278",
"disclosureDate": "2021-07-23",
"transactionDate": "2021-03-29",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/3bdd9340-7c8c-4ed0-898d-dad3835940d2/"
},
{
"symbol": "REGN",
"senateID": "W000802",
"disclosureDate": "2018-01-10",
"transactionDate": "2017-12-18",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/b7108304-8635-48de-a7aa-bb54dd71723a/"
},
{
"symbol": "REGN",
"senateID": "W000802",
"disclosureDate": "2017-06-08",
"transactionDate": "2017-05-16",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/b33c92f5-43d9-430a-8c52-7e5c29954e6d/"
},
{
"symbol": "REGN",
"senateID": "W000802",
"disclosureDate": "2016-10-07",
"transactionDate": "2016-09-06",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/aad1827a-05d8-4b8f-96ed-f3e5f8c925ab/"
},
{
"symbol": "REGN",
"senateID": "W000802",
"disclosureDate": "2016-09-09",
"transactionDate": "2016-09-06",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/9ccfe7a6-66c2-478e-be77-0db00e97d1ab/"
},
{
"symbol": "REGN",
"senateID": "W000802",
"disclosureDate": "2016-06-16",
"transactionDate": "2016-05-24",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Regeneron Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/9579d098-4992-4d7a-b7da-75f6b195ed9d/"
},
{
"symbol": "REGN",
"senateID": "C001035",
"disclosureDate": "2014-02-05",
"transactionDate": "2014-01-30",
"firstName": "Susan Margaret",
"lastName": "Collins",
"office": "Susan M Collins",
"district": "ME",
"owner": "Spouse",
"assetDescription": "Regeneron Pharmaceuticals, Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/6aff1c56-7c0a-4767-a697-e9cc97c69c2d/"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2026-10-09",
"transactionDate": "2026-09-04",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9116376.pdf"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2026-08-12",
"transactionDate": "2026-07-07",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9116267.pdf"
},
{
"symbol": "REGN",
"senateID": "C001123",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-15",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034713.pdf"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2026-05-13",
"transactionDate": "2026-04-13",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9115822.pdf"
},
{
"symbol": "REGN",
"senateID": "L000595",
"disclosureDate": "2026-03-13",
"transactionDate": "2026-02-12",
"firstName": "Julia",
"lastName": "Letlow",
"office": "Julia Letlow",
"district": "LA05",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034106.pdf"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2026-02-10",
"transactionDate": "2026-01-29",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/8221322.pdf"
},
{
"symbol": "REGN",
"senateID": "C001123",
"disclosureDate": "2025-12-15",
"transactionDate": "2025-11-18",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033619.pdf"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2025-10-03",
"transactionDate": "2025-09-29",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "REGENERON PHARMACEUTICAL INC CMN",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/9115679.pdf"
},
{
"symbol": "REGN",
"senateID": "K000389",
"disclosureDate": "2025-09-12",
"transactionDate": "2025-08-26",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/9115642.pdf"
},
{
"symbol": "REGN",
"senateID": "B001327",
"disclosureDate": "2025-06-10",
"transactionDate": "2025-05-15",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030482.pdf"
},
{
"symbol": "REGN",
"senateID": "D000032",
"disclosureDate": "2025-05-26",
"transactionDate": "2025-04-10",
"firstName": "Byron",
"lastName": "Donalds",
"office": "Byron Donalds",
"district": "FL19",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030342.pdf"
},
{
"symbol": "REGN",
"senateID": "D000032",
"disclosureDate": "2025-05-26",
"transactionDate": "2025-04-10",
"firstName": "Byron",
"lastName": "Donalds",
"office": "Byron Donalds",
"district": "FL19",
"owner": "Spouse",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030342.pdf"
},
{
"symbol": "REGN",
"senateID": "J000310",
"disclosureDate": "2025-05-15",
"transactionDate": "2025-04-01",
"firstName": "Julie",
"lastName": "Johnson",
"office": "Julie Johnson",
"district": "TX32",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030296.pdf"
},
{
"symbol": "REGN",
"senateID": "S001229",
"disclosureDate": "2025-05-09",
"transactionDate": "2025-04-07",
"firstName": "Jefferson",
"lastName": "Shreve",
"office": "Jefferson Shreve",
"district": "IN06",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030231.pdf"
},
{
"symbol": "REGN",
"senateID": "B001327",
"disclosureDate": "2025-05-08",
"transactionDate": "2025-04-08",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030291.pdf"
},
{
"symbol": "REGN",
"senateID": "B001327",
"disclosureDate": "2025-03-28",
"transactionDate": "2025-02-25",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029034.pdf"
},
{
"symbol": "REGN",
"senateID": "J000310",
"disclosureDate": "2025-03-13",
"transactionDate": "2025-02-12",
"firstName": "Julie",
"lastName": "Johnson",
"office": "Julie Johnson",
"district": "TX32",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20027936.pdf"
},
{
"symbol": "REGN",
"senateID": "J000310",
"disclosureDate": "2025-02-12",
"transactionDate": "2025-01-15",
"firstName": "Julie",
"lastName": "Johnson",
"office": "Julie Johnson",
"district": "TX32",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026762.pdf"
},
{
"symbol": "REGN",
"senateID": "G000583",
"disclosureDate": "2025-02-11",
"transactionDate": "2025-01-24",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026732.pdf"
},
{
"symbol": "REGN",
"senateID": "J000309",
"disclosureDate": "2024-12-12",
"transactionDate": "2024-11-01",
"firstName": "Jonathan",
"lastName": "Jackson",
"office": "Jonathan Jackson",
"district": "IL01",
"owner": "Joint",
"assetDescription": "Regeneron Pharmaceuticals, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/20026313.pdf"
}
],
"dark_pool": [
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:42:24.668000Z",
"size": 200.0,
"price": 803.63,
"premium": 160726.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:41:58.571000Z",
"size": 200.0,
"price": 804.63,
"premium": 160926.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:41:43.698000Z",
"size": 200.0,
"price": 804.17,
"premium": 160834.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:41:18.332000Z",
"size": 200.0,
"price": 804.1,
"premium": 160820.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:40:19.031000Z",
"size": 200.0,
"price": 800.7,
"premium": 160140.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:40:19.011000Z",
"size": 200.0,
"price": 800.81,
"premium": 160162.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:39:47.113000Z",
"size": 200.0,
"price": 800.32,
"premium": 160064.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "REGN",
"executed_at": "2026-10-20T13:40:10.425000Z",
"size": 199.0,
"price": 799.5976,
"premium": 159119.9224,
"volume": 199.0,
"trade_code": " "
}
],
"ats": {
"symbol": "REGN",
"date": "20261019",
"ats_volume": 0,
"total_volume": 170006,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261019",
"ats_ratio": 0.0
},
{
"date": "20261016",
"ats_ratio": 0.0
},
{
"date": "20261015",
"ats_ratio": 0.0
},
{
"date": "20261014",
"ats_ratio": 0.0
},
{
"date": "20261013",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "REGN",
"days": [
{
"date": "2026-10-20",
"close": 804.63,
"vwap": 797.45,
"volume": 38878,
"vwap_discount_pct": -0.89
},
{
"date": "2026-10-19",
"close": 782.04,
"vwap": 785.34,
"volume": 489580,
"vwap_discount_pct": 0.42
},
{
"date": "2026-10-16",
"close": 790.74,
"vwap": 792.85,
"volume": 653725,
"vwap_discount_pct": 0.27
},
{
"date": "2026-10-15",
"close": 796.34,
"vwap": 800.34,
"volume": 798909,
"vwap_discount_pct": 0.5
},
{
"date": "2026-10-14",
"close": 778.36,
"vwap": 774.62,
"volume": 879091,
"vwap_discount_pct": -0.48
}
],
"avg_vwap_discount_pct": -0.04,
"signal": "Neutral"
},
"options_flow": [
{
"open_interest": 248,
"size": 97,
"implied_volatility": "0.3491152813677255",
"premium": "378300.00",
"executed_at": "2026-10-20T13:41:23.870000Z",
"nbbo_ask": "43.00",
"delta": "-0.3724452857500498",
"price": "39.00",
"sector": "Healthcare",
"strike": "780",
"option_chain_id": "REGN270115P00780000",
"option_type": "put",
"expiry": "2027-01-15",
"volume": 97,
"nbbo_bid": "39.00",
"underlying_price": "804.37",
"underlying_symbol": "REGN"
}
],
"net_premium": {
"ticker": "REGN",
"net_call_premium": "6450.00",
"net_put_premium": "-386925.00",
"call_premium": "21060.00",
"put_premium": "388870.00",
"bullish_premium": "401230.00",
"bearish_premium": "7855.00",
"put_call_ratio": "7.50",
"iv_rank": "46.621",
"implied_move_perc": "0.072",
"gex_ratio": "0.63011087204164122612",
"gex_net_change": "-208.6732",
"gex_call": "3819.7129",
"gex_put": "-2106.9876",
"gex_net": 1712.7253,
"gex_call_delta": "721865.7931",
"gex_put_delta": "-239392.4711",
"gex_date": "2026-10-20"
},
"hot_chains": [
{
"underlying_symbol": "REGN",
"expires": "2027-01-15",
"open_interest": 248,
"option_type": "put",
"delta": -0.406641924493296,
"ask_volume": 0,
"last_price": "39.00",
"implied_volatility": "0.3491152813677255",
"gamma": 0.00307628801116733,
"avg_price": "39.00",
"bid_volume": 97,
"nbbo_ask": "43.00",
"strike": "780",
"option_symbol": "REGN270115P00780000",
"total_premium": "378300.00",
"iv": 0.32249550712459,
"volume": 97,
"nbbo_bid": "38.20"
},
{
"underlying_symbol": "REGN",
"expires": "2026-11-20",
"open_interest": 17,
"option_type": "put",
"delta": -0.295543135661435,
"ask_volume": 0,
"last_price": "16.50",
"implied_volatility": "0.3773079690693409",
"gamma": 0.00412308279777071,
"avg_price": "16.500000000000000000000000000",
"bid_volume": 5,
"nbbo_ask": "20.30",
"strike": "760",
"option_symbol": "REGN261120P00760000",
"total_premium": "8250.00",
"iv": 0.357662841769452,
"volume": 5,
"nbbo_bid": "14.50"
},
{
"underlying_symbol": "REGN",
"expires": "2026-10-30",
"open_interest": 19,
"option_type": "call",
"delta": 0.390232769691494,
"ask_volume": 2,
"last_price": "18.70",
"implied_volatility": "0.468928516380349",
"gamma": 0.00606274193403416,
"avg_price": "18.7000",
"bid_volume": 3,
"nbbo_ask": "20.30",
"strike": "820",
"option_symbol": "REGN261030C00820000",
"total_premium": "9350.00",
"iv": 0.472058635900862,
"volume": 5,
"nbbo_bid": "14.80"
},
{
"underlying_symbol": "REGN",
"expires": "2026-10-23",
"open_interest": 154,
"option_type": "call",
"delta": 0.1088365857252138,
"ask_volume": 2,
"last_price": "1.50",
"implied_volatility": "0.4171575314398664",
"gamma": 0.00592943552148814,
"avg_price": "1.2000000000000000000000000000",
"bid_volume": 1,
"nbbo_ask": "2.00",
"strike": "840",
"option_symbol": "REGN261023C00840000",
"total_premium": "480.00",
"iv": 0.416226882316935,
"volume": 4,
"nbbo_bid": "1.00"
},
{
"underlying_symbol": "REGN",
"expires": "2026-10-23",
"open_interest": 53,
"option_type": "call",
"delta": 0.437426702275987,
"ask_volume": 1,
"last_price": "11.00",
"implied_volatility": "0.3958855102580506",
"gamma": 0.01292126833141232,
"avg_price": "8.5500",
"bid_volume": 1,
"nbbo_ask": "13.10",
"strike": "805",
"option_symbol": "REGN261023C00805000",
"total_premium": "1710.00",
"iv": 0.403309768636984,
"volume": 2,
"nbbo_bid": "6.30"
},
{
"underlying_symbol": "REGN",
"expires": "2026-11-20",
"open_interest": 12,
"option_type": "call",
"delta": 0.246583561146914,
"ask_volume": 0,
"last_price": "8.80",
"implied_volatility": "0.3286514294693981",
"gamma": 0.0037058037837178,
"avg_price": "8.80",
"bid_volume": 1,
"nbbo_ask": "15.20",
"strike": "865",
"option_symbol": "REGN261120C00865000",
"total_premium": "880.00",
"iv": 0.36351216386008,
"volume": 1,
"nbbo_bid": "5.20"
},
{
"underlying_symbol": "REGN",
"expires": "2027-02-19",
"open_interest": 78,
"option_type": "call",
"delta": 0.542502889305984,
"ask_volume": 1,
"last_price": "61.40",
"implied_volatility": "0.331995082121389",
"gamma": 0.00227465741654851,
"avg_price": "61.40",
"bid_volume": 0,
"nbbo_ask": "69.60",
"strike": "800",
"option_symbol": "REGN270219C00800000",
"total_premium": "6140.00",
"iv": 0.376766395488256,
"volume": 1,
"nbbo_bid": "61.40"
},
{
"underlying_symbol": "REGN",
"expires": "2026-12-18",
"open_interest": 2,
"option_type": "put",
"delta": -0.103582494717174,
"ask_volume": 1,
"last_price": "6.25",
"implied_volatility": "0.3690368109551092",
"gamma": 0.001582197398960687,
"avg_price": "6.25",
"bid_volume": 0,
"nbbo_ask": "9.90",
"strike": "675",
"option_symbol": "REGN261218P00675000",
"total_premium": "625.00",
"iv": 0.353076024638578,
"volume": 1,
"nbbo_bid": "1.90"
}
],
"gamma_profile": {
"ticker": "REGN",
"spot": 803.46,
"date": "2026-10-20",
"flip_point": 818.86,
"net_gex": 1712.73,
"call_walls": [
{
"strike": 800.0,
"gex": 300.75
},
{
"strike": 780.0,
"gex": 272.99
},
{
"strike": 900.0,
"gex": 238.92
}
],
"put_walls": [
{
"strike": 780.0,
"gex": -317.53
},
{
"strike": 720.0,
"gex": -164.15
},
{
"strike": 740.0,
"gex": -159.95
}
],
"by_strike": [
{
"strike": 752.5,
"call_gex": 2.74,
"put_gex": -0.47,
"net_gex": 2.27
},
{
"strike": 755.0,
"call_gex": 25.25,
"put_gex": -7.67,
"net_gex": 17.58
},
{
"strike": 757.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 760.0,
"call_gex": 103.81,
"put_gex": -140.43,
"net_gex": -36.62
},
{
"strike": 765.0,
"call_gex": 8.07,
"put_gex": -10.95,
"net_gex": -2.88
},
{
"strike": 770.0,
"call_gex": 87.74,
"put_gex": -34.7,
"net_gex": 53.04
},
{
"strike": 775.0,
"call_gex": 7.21,
"put_gex": -16.37,
"net_gex": -9.16
},
{
"strike": 780.0,
"call_gex": 272.99,
"put_gex": -317.53,
"net_gex": -44.54
},
{
"strike": 785.0,
"call_gex": 43.86,
"put_gex": -5.62,
"net_gex": 38.24
},
{
"strike": 790.0,
"call_gex": 162.13,
"put_gex": -147.7,
"net_gex": 14.43
},
{
"strike": 795.0,
"call_gex": 116.68,
"put_gex": -14.85,
"net_gex": 101.83
},
{
"strike": 800.0,
"call_gex": 300.75,
"put_gex": -120.23,
"net_gex": 180.53
},
{
"strike": 805.0,
"call_gex": 86.14,
"put_gex": -8.69,
"net_gex": 77.46
},
{
"strike": 810.0,
"call_gex": 82.03,
"put_gex": -23.81,
"net_gex": 58.21
},
{
"strike": 815.0,
"call_gex": 9.19,
"put_gex": -0.48,
"net_gex": 8.71
},
{
"strike": 820.0,
"call_gex": 164.12,
"put_gex": -44.97,
"net_gex": 119.14
},
{
"strike": 825.0,
"call_gex": 29.72,
"put_gex": 0.0,
"net_gex": 29.72
},
{
"strike": 830.0,
"call_gex": 75.68,
"put_gex": -7.83,
"net_gex": 67.86
},
{
"strike": 835.0,
"call_gex": 10.55,
"put_gex": 0.0,
"net_gex": 10.55
},
{
"strike": 840.0,
"call_gex": 200.43,
"put_gex": -25.55,
"net_gex": 174.88
},
{
"strike": 845.0,
"call_gex": 2.94,
"put_gex": 0.0,
"net_gex": 2.94
},
{
"strike": 850.0,
"call_gex": 49.27,
"put_gex": -5.91,
"net_gex": 43.37
},
{
"strike": 855.0,
"call_gex": 9.47,
"put_gex": -2.03,
"net_gex": 7.44
},
{
"strike": 860.0,
"call_gex": 100.7,
"put_gex": -34.53,
"net_gex": 66.17
},
{
"strike": 865.0,
"call_gex": 4.39,
"put_gex": 0.0,
"net_gex": 4.39
}
]
},
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 0,
"top": [
{
"strike": "1100",
"oi_change": 0,
"type": "call"
},
{
"strike": "1000",
"oi_change": 0,
"type": "call"
},
{
"strike": "1140",
"oi_change": 0,
"type": "call"
},
{
"strike": "280",
"oi_change": 0,
"type": "put"
},
{
"strike": "780",
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": 0.6,
"D": 3.2,
"P": 51.0,
"O": 57.4,
"C": 19.6,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.8,
"ranked": true,
"components": {
"M": 45.2,
"T": 60.5,
"RS": 100.0,
"V": 0.0,
"F": 100.0,
"OI": null,
"S": 66.2,
"IV": -5.4,
"B": 100.0,
"Liquidity": 0.0,
"OpeningConfidence": 0.0,
"FlowAgreement": 75.0,
"StrikeBreadth": 16.7
},
"drivers": [
"+ aggressive flow +100",
"+ block activity +100",
"+ relative strength +100",
"+ skew +66",
"+ trend +60"
]
}
}
Data:
{
"vix": 16.87,
"sp500": 7744.06,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.33,
"hy_spread": 3.25,
"treasury": {
"date": "2026-10-16",
"month1": 4.12,
"month2": 4.17,
"month3": 4.26,
"month6": 4.34,
"year1": 4.46,
"year2": 4.74,
"year3": 4.82,
"year5": 4.89,
"year7": 4.98,
"year10": 5.09,
"year20": 5.47,
"year30": 5.43
},
"events": []
}
Data:
{
"days": 102,
"patterns": [
{
"name": "VWAP Touch",
"count": 102,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 99,
"pct": 97
},
{
"name": "Woodie Pivot Touch",
"count": 96,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 91,
"pct": 89
},
{
"name": "Open Retracement",
"count": 75,
"pct": 74
},
{
"name": "Gap Fill",
"count": 71,
"pct": 70
},
{
"name": "Darvas Box",
"count": 28,
"pct": 27
},
{
"name": "High Vol Open",
"count": 23,
"pct": 23
},
{
"name": "Power Hour",
"count": 14,
"pct": 14
}
]
}